drugset / Trial / NCT01808534

Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors

NCT01808534

Phase 2 Terminated 5 enrolled Indiana University Alaunos Therapeutics · collab
NaSingle-groupOpen-labelTreatment

Summary

This phase II trial studies how well palifosfamide works in treating patients with recurrent germ cell tumors. Drugs used in chemotherapy, such as palifosfamide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing

Timeline

Start
2013-02
Primary completion
2014-11
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Palifosfamide Small molecule Intravenous